Cerevel Therapeutics
Cerevel Therapeutics is a biopharmaceutical company.
| Company Details | |
|---|---|
| Title | Cerevel Therapeutics |
| Industries | Biotechnology, Pharmaceutical, Therapeutics |
| Headquarters Regions | Greater Boston Area, East Coast, New England |
| Headquarters Location | Boston, Massachusetts, United States |
| No Of Employees | 251-500 |
| Operating Status | Active |
Description
Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson’s disease and substance use disorder.